Co-Founder of Develco Pharma
Dirk gained experience as an analyst and project manager in the development with Roche as well as project director and executive board member at Cimex. Until his sudden death, Dirk was responsible for business development, project management and clinical development at Develco Pharma.
Co-Founder of Develco Pharma
Mathias gained his experience in the pharmaceutical industry with Ciba-Geigy / Novartis in technical operations and as executive board member at Cimex. Mathias is Executive Director responsible for the strategic development at Develco.
Andrea is responsible for supply Chain and Technical Operations since February 2018 at Develco Pharma AG. She has more than 25 years experience in pharmaceutical development of oral dosage forms and pharmaceutical production gained at Hoffmann la Roche and Novartis Pharma. During the last 5 years she was member of the management team at the production site Novartis Pharma in Wehr. Since the beginning she is closely liaised to the activities of Develco as spouse of the founder Dr. Dirk Kramer.
An employee from the beginning
Hélène met Dirk and Mathias at Cimex in 2002, where, after her academic studies in Strasbourg and Tübingen, she led the pharmaceutical technical development. At Develco, Hélène is responsible for research and development.
An employee from the beginning
Following his academic studies in Lyon, Villeurbanne and Milwaukee Marc started at Cimex on the same day as Dirk and Mathias, where he headed the analytical development. His function at Develco is Chief Operation Officer responsible for administration, human resources, and IT.
With Develco since 2015
Prior to joining Develco, Thomas was the production manager at Konapharma and site manager of the Steiner Arzneimittelgesellschaft of the Aristo Pharma group. At Develco, Thomas is Technical Director and Managing Director in charge of the realisation of the new production site.
With Develco since 2016
Markus has been a long time business friend of Dirk, Mathias, Hélène and Marc. Over more than 15 years, he and his company YES (now PharmaLex) have supported Develco in regulatory and medical affairs. After more than 20 years as managing director he retired from his company and now represents Develco as Director Business Development & Licensing in the areas of business development and licensing.
With Develco since 2018
Since 2018, Philipp Kläy took over as new CFO at Develco.
Philipp has a broad experience as CFO within many companies, whereof most in the pharmaceutical area (trade of API’s). He studied Business Economics and graduated his EMBA studies.